Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (011721 IgG) | # Peptides (by Search Engine): B2 Sequest HT (011721 MIP 3 WT) | # Peptides (by Search Engine): C2 Sequest HT (011721 MIP 1 AKO) | # Peptides (by Search Engine): D2 Sequest HT (011721 MIP 2 DKO) | # PSMs (by Search Engine): A2 Sequest HT (011721 IgG) | # PSMs (by Search Engine): B2 Sequest HT (011721 MIP 3 WT) | # PSMs (by Search Engine): C2 Sequest HT (011721 MIP 1 AKO) | # PSMs (by Search Engine): D2 Sequest HT (011721 MIP 2 DKO) | Abundance: F1: Sample, 011721 IgG | Abundance: F2: Sample, 011721 MIP 3 WT | Abundance: F3: Sample, 011721 MIP 1 AKO | Abundance: F4: Sample, 011721 MIP 2 DKO | Abundances Count: F1: Sample, 011721 IgG | Abundances Count: F2: Sample, 011721 MIP 3 WT | Abundances Count: F3: Sample, 011721 MIP 1 AKO | Abundances Count: F4: Sample, 011721 MIP 2 DKO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | P01901 | "H-2 class I histocompatibility antigen, K-B alpha chain OS=Mus musculus OX=10090 GN=H2-K1 PE=1 SV=1" | 0 | 25.559 | 22 | 7 | 23 | 4 | 369 | 41.3 | 6.39 | 5 | 3 | 6 | 6 | 6 | 11 | 17976.82813 | 1879349.938 | 1437318.188 | 5299572.25 | 1 | 4 | 4 | 4 | defense response;regulation of biological process;response to stimulus | cell surface;endoplasmic reticulum;Golgi;membrane | protein binding;RNA binding | "Pf00129, Pf06623, Pf07654" | 14972 | ENSMUSG00000061232.15 | H2-K1 | 17 | Endocytosis; Herpes simplex infection; Allograft rejection; Epstein-Barr virus infection; Cell adhesion molecules (CAMs); HTLV-I infection; Phagosome; Graft-versus-host disease; Viral myocarditis; Antigen processing and presentation; Type I diabetes mellitus; Natural killer cell mediated cytotoxicity; Autoimmune thyroid disease; Viral carcinogenesis | 0 |